Cambridge Cognition Holdings plc ("Cambridge Cognition") (AIM: COG), the neuroscience technology company specialising in ...

Cambridge Cognition, the neuroscience technology company specialising in digital cognitive assessments, and Ivory, a ...

Our Bureau, Bengaluru Thursday, February 19, 2026, 17:50 Hrs [IST] ...

Forget the hype about AI "solving" human cognition, new research suggests unified models like Centaur are just overfitted "black boxes" that fail to understand basic instructions.

AIM-listed digital assessments group will commercialise CANTAB Pathway in India across healthcare providers and consumer markets Cambridge Cognition Holdings PLC (AIM:COG) has struck an agreement with ...

Cambridge Cognition has partnered with Indian brain health start-up Ivory to commercialise its CANTAB Pathway digital cognitive assessments.

AIM-quoted Cambridge Cognition saw its share price shoot to its highest price in almost a year after announcing a potentially game-changing alliance with Ivory in India.

Cambridge Cognition announced on Monday that it has entered into a commercialisation agreement with India-based brain health platform Ivory to deploy its ‘CANTAB Pathway’ digital cognitive assessment ...

Cambridge Cognition Holdings PLC (AIM:COG) shares rose 14% to 45p on Monday after the AIM-listed neuroscience technology company announced a partnership to commercialise its CANTAB Pathway cognitive ...

New research warns conversational AI may reinforce false beliefs by validating and expanding users’ narratives, increasing ...

The company’s cross-disciplinary team lead by a Triple-Dr, Berenika Maciejewicz, applies bioengineering and AI towards human lifespan and healthspan extension.

Research suggests that high use of social media and AI chat tools may affect your attention and memory. But there is ...